ELAN News and Press, Elanco Animal Health Incorporated From 09/27/22

Summary Jeff Smith’s 13F portfolio value decreased from $7.54B to $5.50B this quarter. Starboard Value increased NortonLifeLock and Mercury Systems while decreasing ON Semiconductor, Huntsman Corp, Corteva, Enovis, and Kohl’s. The largest three individual stock p...

Summary A high level of restructuring is occurring with the Healthcare industry’s largest constituents. Most restructuring is taking the form of splits or spin-offs, but not all incidences look beneficial. This article will summarize coming transactions and provide comm...

The shares of the veterinary science company Elanco Animal Health ( NYSE: ELAN ) jumped ~9% in the morning hours Friday after activist investor Sachem Head Capital Management, led by founder Scott Ferguson disclosed a ~6% stake in the company. Friday’s regulator...

Scott Ferguson stepping down from the Board Sachem Head expresses confidence in Elanco’s leadership and strategy Elanco Animal Health Incorporated (NYSE: ELAN) announced today that Scott Ferguson, founder and managing partner of Sachem Head Capital Management LP (...

Elanco Animal Health Incorporated (NYSE: ELAN) will attend the Morgan Stanley 20th Annual Global Healthcare Conference on Monday, September 12, 2022. Jeff Simmons, president and CEO, will participate in a fireside chat at 2:50 p.m., Eastern time. A live audio webcast will be availab...

Elanco Animal Health ( NYSE: ELAN ) on Tuesday hit another 52-week low, this time to $16.05. Since August 4, the company has reached a new 52-week low seven times. Although Elanco ( ELAN ) beat on the top line in its recent Q2 2022 results , it also narrowed it...

A lackluster session ended with mild gains on Thursday, as investors looked for direction after a modest decline the previous session halted a recent upswing for the major U.S. equity averages. While the overall action remained restrained, Thursday also saw its share of significant move...

Morgan Stanley has downgraded Elanco Animal Health ( NYSE: ELAN ) to Equal Weight from Overweight, noting the lingering concerns over its bleak prospects amid macro and company-specific headwinds. Analysts Erin Wright and Justin X Wang point to ELAN's Q2 financials and argue...

Elanco Animal Health ( NYSE: ELAN ) on Tuesday hit a 52-week low of $18.38. Year to date, shares are down ~33% . Over the last year, they have declined ~40% . Elanco ( ELAN ) recently narrowed its fiscal 2022 guidance. In July, Goldman Sachs downgrade...

Report Aligned with Leading Sustainability Frameworks and Elanco’s Healthy Purpose™ Sustainability Approach Elanco Animal Health Incorporated (NYSE:ELAN) today released its 2021 Environmental, Social and Governance (ESG) Report “Changing The World One ...